The selloff on this stock is WAY overdone IMO...We're 0.2c below the cap raise prise.Considering what they could be sitting on, it's cheap as chips especially in this gold climate.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025